Status:
COMPLETED
Performance of the SeptiCyte LAB Test for Antibiotic Stewardship in Mesenteric Ischemia
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Acute Mesenteric Ischemia
Sepsis Bacterial
Eligibility:
All Genders
18-90 years
Brief Summary
This study will help determine whether the SeptiCyte LAB test can accurately differentiate between SIRS and actual infections in postoperative patients, potentially reducing unnecessary antibiotic use...
Detailed Description
Introduction Early diagnosis of bacterial infections is crucial in intensive care, as conditions such as sepsis and septic shock are emergencies with high mortality rates. Conversely, Systemic Inflamm...
Eligibility Criteria
Inclusion
- Patient aged over 18 years
- Affiliated to health assurance system
- Hospitalized in the ICU for confirmed mesenteric ischemia\* for less than 24 hours with an indication for laparotomy
- Hospitalized in the ICU for confirmed mesenteric ischemia\* who underwent laparotomy for revascularization or digestive resection less than 24 hours ago
- Intraoperative bacteriological samples and blood cultures performed within 24 hours of medical management
Exclusion
- decline to participate
- no consent available
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2024
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06507423
Start Date
August 1 2024
End Date
November 1 2024
Last Update
April 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Nancy
Nancy, Lorraine, France, 54500